1 assistance programs for Venofer patients · 1 open today
One manufacturer program — AR Assist provides free drug to uninsured patients. There is no commercial copay card and no foundation fund open today.
Select the patient's insurance to see what applies.
Current status · Award amount · Eligibility · Direct application link · verified June 18, 2026
Venofer · Non-dialysis CKD (NDD-CKD) · Commercial insurance
No program matches Commercial insurance + Non-dialysis CKD (NDD-CKD) today.
Example · Venofer · 200 mg · 200 units · commercial plan · deductible met · 20% coinsurance · allowed amounts at the Medicare reference rate
| Without assistance | With American Regent Patient Assistance | |
|---|---|---|
| Drug responsibility | $9.08 | $0.00 |
| Administration (96374) | $7.55 | $7.55 |
| Patient owes | $16.63 | $7.55 |
Estimated patient savings: $9.08
CareCost calculates the drug and administration lines using the patient’s payer rate and benefits; this example uses the Medicare rate as a reference.
Also available if this patient’s coverage falls short
Free AR Assist Patient Assistance Program for eligible patients
Change the diagnosis to see only the programs that apply to your patient.
| Task | ✓ |
|---|---|
| Find programs for the patient's insurance | ✓ |
| See whether the program is open | ✓ |
| See maximum award | ✓ |
| Review key eligibility requirements | ✓ |
| Open the official application | ✓ |
| Calculate cost before assistance | ✓ |
| Apply the program benefit | ✓ |
| Calculate what the patient still owes | ✓ |
Uninsured or a coverage gap — AR Assist (American Regent) ships Venofer free directly to the provider for patients who are uninsured or have a coverage gap, at or below 400% of the federal poverty level. It covers the drug only; the 96374 administration code and any office visit are billed separately. View current program ↑
Commercial insurance — American Regent runs no copay card for Venofer. A commercially insured patient's coinsurance is not reduced by any manufacturer program; the estimator's Medigap and payer-rate tools on the cost page are what changes what that patient owes.
Medicare — Manufacturer copay savings cannot be used when government insurance is paying for Venofer; the federal Anti-Kickback Statute is why, per HHS OIG guidance on copayment coupons. AR Assist's own eligibility is limited to uninsured patients regardless. No foundation fund in this corpus lists J1756 as a matched drug today — the one iron-deficiency-anemia fund on file (PAN Foundation) is matched to Monoferric's J-code, not Venofer's, and is currently closed.
Why the setting selector doesn't change the result — AR Assist's eligibility is set by insurance status, not by CKD setting or dialysis status. Every regimen on the cost page — NDD-CKD, HDD-CKD, or PDD-CKD — shares the same D63.1 diagnosis code, and AR Assist applies the same way to all three.
No. American Regent runs no copay card for commercially insured Venofer patients. Its only patient program is AR Assist, a free-drug program for uninsured patients or patients with a coverage gap — it does not reduce a commercial patient's coinsurance.
Not from American Regent. AR Assist's eligibility is limited to uninsured patients, and no foundation fund in this corpus lists J1756 as a matched drug today.
Patients who are uninsured or have a coverage gap, at or below 400% of the federal poverty level. AR Assist ships the drug free directly to the provider — no insurance billing involved. Apply on venofer.com/arassist ↗
No. AR Assist covers only the drug itself; the 96374 administration code and any office visit are billed separately.
None today. The one iron-deficiency-anemia foundation fund in this corpus (PAN Foundation) is matched to Monoferric's J-code, not to J1756, and it is currently closed.
Data current: programs verified Jun 18, 2026
AR Assist Patient Assistance Program (American Regent, venofer.com/arassist) · PAN Foundation. Every program links directly to its official source or application page.
Last program check: .
Reviewed September 12, 2026 by Erin Rose, CareCost Estimate founder. Methodology →